Literature DB >> 24668009

MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis.

Anita Andreano1, Gilda Rechichi, Paola Rebora, Sandro Sironi, Maria Grazia Valsecchi, Stefania Galimberti.   

Abstract

OBJECTIVES: To compare the diagnostic accuracy of dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) MR imaging in detecting deep myometrial invasion in endometrial cancer, using surgical-pathological staging as reference standard.
METHODS: After searching a wide range of electronic databases and screening titles/abstracts, we obtained full papers for potentially eligible studies and evaluated according to predefined inclusion criteria. Quality assessment was conducted by adapting the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) checklist. From each study, we extracted information on diagnostic performance of DW and DCE sequences. After exploring heterogeneity, we adopted a bivariate generalized linear mixed model to compare the effect of the two MR sequences jointly on sensitivity and specificity.
RESULTS: Nine studies (442 patients) were considered. Significant evidence of heterogeneity was found only for specificity, both in DW and DCE imaging (I (2)  = 70.8 % and 70.6 %). Pooled sensitivity of DW and DCE was 0.86 and specificity did not significantly differ (p = 0.16) between the two sequences (DW = 0.86 and DCE = 0.82). No difference was found between 3-T and 1.5-T MR. There was no evidence of publication bias.
CONCLUSIONS: MR diagnostic accuracy in presurgical detection of deep myometrial infiltration in endometrial cancer is high. DCE and DW imaging do not differ in sensitivity and specificity. KEY POINTS: Myometrial invasion is the most important morphological prognostic feature of endometrial cancer. MR diagnostic accuracy in presurgical detection of deep myometrial infiltration is high. MR examination including T2 and DCE imaging is considered the reference standard. DW imaging has been increasingly employed with heterogeneous results. This meta-analysis shows that DCE and DW do not differ in diagnostic accuracy.

Entities:  

Mesh:

Year:  2014        PMID: 24668009     DOI: 10.1007/s00330-014-3139-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  53 in total

1.  Multiparametric imaging of tumor response to therapy.

Authors:  Anwar R Padhani; Kenneth A Miles
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

2.  Revised FIGO staging for carcinoma of the endometrium.

Authors:  William Creasman
Journal:  Int J Gynaecol Obstet       Date:  2009-04-03       Impact factor: 3.561

3.  Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging.

Authors:  H Hricak; B Hamm; R C Semelka; C E Cann; T Nauert; E Secaf; J L Stern; K J Wolf
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

4.  FIGO staging system for endometrial cancer: added benefits of MR imaging.

Authors:  Peter Beddy; Ailbhe C O'Neill; Adam K Yamamoto; Helen C Addley; Caroline Reinhold; Evis Sala
Journal:  Radiographics       Date:  2012 Jan-Feb       Impact factor: 5.333

5.  Prognostic significance of gross myometrial invasion with endometrial cancer.

Authors:  D M Larson; G P Connor; S K Broste; B R Krawisz; K K Johnson
Journal:  Obstet Gynecol       Date:  1996-09       Impact factor: 7.661

6.  Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.

Authors:  O Kilickesmez; S Bayramoglu; E Inci; T Cimilli; A Kayhan
Journal:  Acta Radiol       Date:  2009-04       Impact factor: 1.990

7.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

8.  Endometrial cancer: utility of diffusion-weighted magnetic resonance imaging with background body signal suppression at 3T.

Authors:  Jung Min Seo; Chan Kyo Kim; Dongil Choi; Byung Kwan Park
Journal:  J Magn Reson Imaging       Date:  2012-11-13       Impact factor: 4.813

Review 9.  Advanced MRI in malignant neoplasms of the uterus.

Authors:  Aki Kido; Koji Fujimoto; Tomohisa Okada; Kaori Togashi
Journal:  J Magn Reson Imaging       Date:  2013-02       Impact factor: 4.813

Review 10.  Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

Authors:  Daniel M Patterson; Anwar R Padhani; David J Collins
Journal:  Nat Clin Pract Oncol       Date:  2008-02-26
View more
  32 in total

1.  Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.

Authors:  A Stiekema; Car Lok; C M Korse; W J van Driel; V van der Noort; G G Kenter; K K Van de Vijver
Journal:  Virchows Arch       Date:  2017-04-11       Impact factor: 4.064

2.  Pre-operative MRI staging of endometrial cancer in a multicentre cancer network: can we match single centre study results?

Authors:  N D Soneji; N Bharwani; A Ferri; V Stewart; A Rockall
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

3.  Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Authors:  Priya Bhosale; Jingfei Ma; Revathy Iyer; Preetha Ramalingam; Wei Wei; Pamela Soliman; Michael Frumovitz; Vikas Kundra
Journal:  J Magn Reson Imaging       Date:  2015-07-16       Impact factor: 4.813

4.  Assessment of deep myometrial invasion of endometrial cancer on MRI: added value of second-opinion interpretations by radiologists subspecialized in gynaecologic oncology.

Authors:  Sungmin Woo; Sang Youn Kim; Jeong Yeon Cho; Seung Hyup Kim
Journal:  Eur Radiol       Date:  2016-09-21       Impact factor: 5.315

5.  Preoperative staging of endometrial cancer using reduced field-of-view diffusion-weighted imaging: a preliminary study.

Authors:  Takashi Ota; Masatoshi Hori; Hiromitsu Onishi; Makoto Sakane; Takahiro Tsuboyama; Mitsuaki Tatsumi; Atsushi Nakamoto; Tadashi Kimura; Yoshifumi Narumi; Noriyuki Tomiyama
Journal:  Eur Radiol       Date:  2017-07-03       Impact factor: 5.315

6.  Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade.

Authors:  Stephanie Nougaret; Caroline Reinhold; Shaza S Alsharif; Helen Addley; Jocelyne Arceneau; Nicolas Molinari; Boris Guiu; Evis Sala
Journal:  Radiology       Date:  2015-04-30       Impact factor: 11.105

7.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

8.  Preoperative prediction of deep myometrial invasion and tumor grade for stage I endometrioid adenocarcinoma: a simple method of measurement on DWI.

Authors:  Bin Yan; Xiufen Liang; Tingting Zhao; Chen Niu; Caixia Ding; Wenjun Liu
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

Review 9.  Diffusion weighted imaging in gynecological malignancies - present and future.

Authors:  Dinesh Manoharan; Chandan J Das; Ankita Aggarwal; Arun K Gupta
Journal:  World J Radiol       Date:  2016-03-28

Review 10.  Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

Authors:  Stephanie Nougaret; Mariana Horta; Evis Sala; Yulia Lakhman; Isabelle Thomassin-Naggara; Aki Kido; Gabriele Masselli; Nishat Bharwani; Elizabeth Sadowski; Andrea Ertmer; Milagros Otero-Garcia; Rahel A Kubik-Huch; Teresa M Cunha; Andrea Rockall; Rosemarie Forstner
Journal:  Eur Radiol       Date:  2018-07-11       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.